DrugPatentWatch Database Preview

ISRADIPINE Drug Profile

« Back to Dashboard

When do Isradipine patents expire, and when can generic versions of Isradipine launch?

Isradipine is a drug marketed by Elite Labs Inc, Watson Labs Teva, and Mylan Pharms Inc. and is included in three NDAs.

The generic ingredient in ISRADIPINE is isradipine. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the isradipine profile page.

Summary for ISRADIPINE

US Patents:	0
Applicants:	3
NDAs:	3
Suppliers / Packagers:	5
Bulk Api Vendors:	66
Clinical Trials:	8
Patent Applications:	4,485
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	ISRADIPINE at DailyMed

Pharmacology for ISRADIPINE

Ingredient-type	Dihydropyridines
Drug Class	Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists

Medical Subject Heading (MeSH) Categories for ISRADIPINE

Antihypertensive Agents

Calcium Channel Blockers

Vasodilator Agents

Synonyms for ISRADIPINE

(-)-Isradipine

(.+/-.)-Isradipine

(+-)-Isradipine

(+)-isradipine

(+/-)-Isradipine

(non-Isotopelabelled)Isradipine-d7

(plusmn)-isradipine

131970-21-3

2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.

3-Isopropyl 5-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate #

3-isopropyl 5-methyl 4-(benzo[c][1,2,5]oxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

3-methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(4-benzofurazanyl)-2,6-dimethyl-, methyl 1-methylethyl ester, (+-)-

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(4-benzofurazanyl)-2,6-dimethyl-,methyl 1-methylethyl ester, (+-)-

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-(1-methylethyl) ester

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester (9CI)

3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester

3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (.+/-.)-

3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (+-)-

4-(2,1,3-Benzooxadiazol-4-yl)-2.6-dimethyl-1,4-dihydro-3-isopropyloxycarbonylpyridine-5-carboxylic Acid Methyl Ester

4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid methyl 1-methylethyl ester

4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-propan-2-yl ester

4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methhylethyl ester

4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester

4-(4-Benzofurazanyl)-1,4-dihydro-2,-6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester

4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester

4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester

695I931

75695-93-1

88977-22-4

AB00514007

AB00514007_02

AB00514007_03

AB2000202

AC-8539

AC1L1GPE

AC1Q426L

ACM131970213

ACT02697

AK163124

AKOS015895129

AN-7921

Antiviral (genital herpes), PharmaNova

AOB5974

API0003052

BDBM50436176

BG0371

BPBio1_001323

BRD-A90799790-001-03-3

BSPBio_001201

C19H21N3O5

CAS-75695-93-1

CCG-101027

CCG-213711

CHEBI:6073

CHEBI:91953

CHEMBL1648

CHEMBL315436

CHEMBL3211306

CI0041

Clivoten

CPD002529690

CS-2201

CTK8G0407

D00349

D0HC8Q

D0Z7KE

DB00270

DR002052

DSSTox_CID_3179

DSSTox_GSID_23179

DSSTox_RID_76907

DTXSID4023179

DynaCirc

DynaCirc (TN)

Dynacirc CR

DynaCirc, Prescal, PN-200-110, Clivoten, Esradin, Isradipine

DynaCirc;Prescal;PN-200-110;Clivoten;Esradin;Dynacirc

DynaCire

DynaCire CR

Dynacrine

Esradin

FT-0627542

GTPL4488

HE386320

HMJIYCCIJYRONP-UHFFFAOYSA-N

HMS1571M03

HMS2051J12

HMS2098M03

HMS2235O12

HMS3268D21

HMS3393J12

HMS3655C17

HS-0085

HY-B0233

I06-0364

I0876

Icaz

isopropyl 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridinecarboxylate

Isopropyl methyl (.+/-.)-4-(4-benzfurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate

Isopropyl methyl (.+/-.)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate

Isopropyl methyl (+-)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate

Isopropyl Methyl 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimet

Isopropyl Methyl 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate

Isradipin

Isradipine (Dynacirc)

Isradipine (USP/INN)

Isradipine [USAN:INN:BAN]

Isradipine [USAN:USP:INN:BAN]

Isradipine, (+-)-Isomer

Isradipine, (R)-Isomer

Isradipine, (S)-Isomer

Isradipine, >=98% (HPLC), solid

Isradipine, European Pharmacopoeia (EP) Reference Standard

Isradipine, United States Pharmacopeia (USP) Reference Standard

Isradipine(Dynacirc)

Isradipino

Isradipino [Spanish]

Isradipinum

Isradipinum [Latin]

Isrodipine

J-513454

K297

KBio2_000698

KBio2_003266

KBio2_005834

KBioSS_000698

KS-0000118G

Lomir

LS-131190

LS-177211

methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

MFCD00153820

MLS000759425

MLS001424076

MLS002154106

MLS003915633

MLS006010138

MolPort-003-848-292

NC00277

NCGC00016931-01

NCGC00025341-01

NCGC00025341-02

NCGC00025341-03

NCGC00025341-06

NSC-759892

NSC759892

O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Pharmakon1600-02300234

PN 200

PN 200-110

PN 205 033

PN 205 034

PN 205-033

PN 205-034

PN 205033

PN 205034

PN-200

PN-200-110

PN-200, PharmaNova

PN-200110

PN-205-033

PN-205-034

PN205033

PN205034

Prescal

Prescal (TN)

Prestwick0_001021

Prestwick1_001021

Prestwick2_001021

Prestwick3_001021

Rebriden

RL04885

s1662

SAM001246584

SC-16999

SCHEMBL34555

SMR000466320

SMR002529690

SPBio_003062

Spectrum_000218

SR-01000597526

SR-01000597526-2

Tox21_110690

Tox21_110690_1

VA11116

US Patents and Regulatory Information for ISRADIPINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Elite Labs Inc	ISRADIPINE	isradipine	CAPSULE;ORAL	077169-001	Apr 24, 2006	AB	RX	No	No
Watson Labs Teva	ISRADIPINE	isradipine	CAPSULE;ORAL	077317-002	Jan 5, 2006	AB	RX	No	Yes
Elite Labs Inc	ISRADIPINE	isradipine	CAPSULE;ORAL	077169-002	Apr 24, 2006	AB	RX	No	No
Watson Labs Teva	ISRADIPINE	isradipine	CAPSULE;ORAL	077317-001	Jan 5, 2006	AB	RX	No	No